US activists ensure people living with HIV can enrol in COVID-19 vaccine studies
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
COVID-19
HIV organisations oppose active-challenge COVID-19 vaccine studies
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
AVAC webinar with Barney Graham: COVID-19 vaccine targets, timelines, efficacy and ethical issues
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
Equitable access to vaccines against COVID-19
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
Conference opening and making sense of the science
22 July 2020. Related: Conference reports, COVID-19.
HepC drugs for COVID-19: sofosbuvir/daclatasvir show faster recovery and reduced mortality
22 July 2020. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Predictors of response to remdesivir in GS-5773 COVID-19 study
22 July 2020. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Pneumocystis Jirovecii Pneumonia (PJP) mistaken for COVID-19 in late stage undiagnosed: urgency of including HIV testing on admission
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
NYC cohort reports similar outcomes from COVID-19 in HIV positive vs HIV negative adults
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Spanish study reports associations between COVID-19 and HIV treatment including NRTIs
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
UK study reports inhaled interferon-Beta reduces time to recovery from COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Review of COVID-19 in people with immune suppression
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
EMA grants conditional approval for remdesivir in the EU to treat COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Drug price announced for remdesivir – as US buys up world stock
22 July 2020. Related: COVID-19: treatment access, COVID-19.
RECOVERY study reports that lopinavir/r fails to show benefit against COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Hydroxychloroquine and lopinavir/r arms stopped in the WHO SOLIDARITY study
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Individualising management of COVID-19 based on real-time inflammatory responses
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Further positive reports from tocilizumab to treat COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Higher mortality from COVID-19 in London study in Asian or Black compared to white participants
22 July 2020. Related: COVID-19: pathogenesis, COVID-19.
UK study reports antibody responses linked to more severe COVID-19 in higher risk populations
22 July 2020. Related: COVID-19: pathogenesis, COVID-19.
Leading SARS-CoV-2 antibody tests meet specificity but fail current sensitivity guidelines
22 July 2020. Related: COVID-19: diagnostics, COVID-19.
Infectious SARS-CoV-2 in air and on surfaces in London hospitals
22 July 2020. Related: COVID-19: transmission & prevention, COVID-19.
US prisoners have higher mortality rates from COVID-19
22 July 2020. Related: COVID-19: transmission & prevention, COVID-19.
US SARS-CoV-2 epidemic could see 100,000 cases per day: NIAID head Anthony Fauci to Senate hearing
22 July 2020. Related: COVID-19: transmission & prevention, COVID-19.
Research during COVID-19
22 July 2020. Related: COVID-19: research studies, COVID-19: on the web, COVID-19.
Vaccine candidates report phase 3 studies after early safety and immune responses in phase 1/2 studies
22 July 2020. Related: COVID-19: vaccine research, COVID-19.
FDA guidance on COVID-19 vaccine includes minimal target of 50% efficacy
22 July 2020. Related: COVID-19: vaccine research, COVID-19.
Latest studies on HIV/COVID-19 coinfection
26 June 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
HIV positive people in South Africa at increased risk of dying from COVID-19: first data from country with high prevalence of HIV and TB
26 June 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Update on Western Cape data: people with HIV have small increased risks from COVID-19
26 June 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Dexamethasone significantly reduces mortality in subset of patients hospitalised with advanced COVID-19: UK RECOVERY study
26 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Modelling paper suggests hydroxychloroquine dosing was too low to be active against COVID-19 and that higher doses would risk toxicity
26 June 2020. Related: COVID-19: investigational drugs, COVID-19.
FDA contraindication for remdesivir and hydroxychloroquine (HCQ): immediate impact on current HCQ research
26 June 2020. Related: COVID-19: investigational drugs, COVID-19.
UK RECOVERY study stops hydroxychloroquine (HCQ) for COVID-19: more than 1100 deaths question ethics and safety overall
26 June 2020. Related: COVID-19: investigational drugs, COVID-19.
SIMPLE study reports benefit from 5-day but not 10-day remdesivir on moderate COVID-19
26 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Recent papers on convalescent plasma and on ACE inhibitors and angiotensin receptor blockers
26 June 2020. Related: COVID-19: investigational drugs, COVID-19.
BHIVA/THT updated guidelines for social distancing in the UK
26 June 2020. Related: COVID-19: guidelines, COVID-19.
Two PEP studies report no benefit of hydroxychloroquine for preventing CoV-2 infection
26 June 2020. Related: COVID-19: transmission & prevention, COVID-19.
COVID-19 harm reduction programmes in Central and Eastern Europe and Central Asia
26 June 2020. Related: COVID-19: on the web, COVID-19.
HIV and COVID-19 coinfection: case reports, retrospective cohorts and outcomes
1 June 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
UK access to remdesivir approved: but MHRA criteria exclude some who could benefit
1 June 2020. Related: COVID-19: treatment access, COVID-19.
EMA recommends expanding access to remdesivir
1 June 2020. Related: COVID-19: treatment access, COVID-19.
Remdesivir improves recovery time in early COVID-19 infection: first definitive results of benefit
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Convalescent plasma therapy for COVID-19
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Treatment with interferon in early COVID-19
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Famotidine associated with improved clinical outcomes in people hospitalised with COVID-19
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Tocilizumab and remdesivir in new dual therapy study
1 June 2020. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
RETRACTED – Re: No benefit from hydroxychloroquine, with or without macrolide antibiotics in analysis of 96,000 participants
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
BHIVA advice for HIV positive people hospitalised with COVID-19
1 June 2020. Related: COVID-19: guidelines, COVID-19.
Changes in taste and smell as symptoms of COVID-19
1 June 2020. Related: COVID-19: pathogenesis, COVID-19.
BHIVA guidelines on shielding: advice for HIV clinicians, GPs and people living with HIV
1 June 2020. Related: COVID-19: guidelines, COVID-19.
European consensus on HIV and COVID-19: UK (BHIVA), European (EACS), Spanish, German and Polish HIV organisations
1 June 2020. Related: COVID-19: guidelines, COVID-19.
UK guidelines for the treatment of COVID-19: UK prioritises 42 studies
1 June 2020. Related: COVID-19: guidelines, COVID-19: research studies, COVID-19.
Low CD4s and CD8s – but not viral genetics – predict COVID-19 progression
1 June 2020. Related: COVID-19: pathogenesis, COVID-19.
Autopsies show how COVID-19 damages lungs more than flu
1 June 2020. Related: COVID-19: pathogenesis, COVID-19.
Higher rates of serious outcomes in HIV and COVID-19 coinfection in Germany: cautious review
14 May 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
HIV is not linked to higher risk of COVID-19 in large New York cohort
14 May 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Case-studies show darunavir does not protect against CoV-2
14 May 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
COVID-19 could lead to 500,000 excess HIV-related deaths in sub-Saharan Africa linked to interruptions in ART supply
14 May 2020. Related: COVID-19: treatment access, COVID-19.
Remdesivir for COVID-19: randomised study shows similar antiviral effect to placebo
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Other remdesivir news: top results from NIH and Gilead studies – emergency approval in US and Japan
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Potential for tocilizumab to treat moderate to severe COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Detectable viral load and IL-6: a role for tocilizumab or anti-JAK inhibitor baricitinib?
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Rheumatoid arthritis drug anakinra in small study to treat COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.